Toxicological Assessment of Silver Nanoparticles Synthesized through Green Route using Andrographis paniculata

S. Darbar, Srimoyee Saha, K. Pramanik, Atiskumar Chattopadhyay
{"title":"Toxicological Assessment of Silver Nanoparticles Synthesized through Green Route using Andrographis paniculata","authors":"S. Darbar, Srimoyee Saha, K. Pramanik, Atiskumar Chattopadhyay","doi":"10.30799/JNST.175.19050111","DOIUrl":null,"url":null,"abstract":"Article history: Received 12 October 2018 Accepted 28 November 2018 Available online 16 March 2019 Nanomedicine is a combination of nanotechnology and medicine. It provides new direction in medical diagnosis, monitoring and treatment at the level of single molecules or molecular assemblies at the “nano” scale. Additionally, continuing improvement in the pharmacological and therapeutic properties of drugs is driving the revolution in novel drug delivery systems. Nanomedicine is widely explored nowadays for treatment of life threatening diseases, yet comes with various challenges and questions. The present study encapsulates the acute toxicological aspects of the Andrographis paniculata coupled with silver nanoparticles (AP-Ag NP). For acute toxicity studies according to OCED (Organization for Economic Cooperation and Development) guidelines Swiss Albino male mice (6-7 weeks) were used and were given single intraperitoneal dose of 2000 and 5000 mg/kg body weight of the AP-Ag nanoparticle and were observed for mortality and other side effects for 14 days. The individual components of the formulation, viz. silver oxide in surface modified nano form and at low dose, and Andrographis paniculata are both biocompatible materials. No changes were found for general appearance, behavior and body weight, thus concluding that the nanocomposite formulation does not have a single dose toxicity.","PeriodicalId":23586,"journal":{"name":"Volume 5,Issue 1,2019","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Volume 5,Issue 1,2019","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30799/JNST.175.19050111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Article history: Received 12 October 2018 Accepted 28 November 2018 Available online 16 March 2019 Nanomedicine is a combination of nanotechnology and medicine. It provides new direction in medical diagnosis, monitoring and treatment at the level of single molecules or molecular assemblies at the “nano” scale. Additionally, continuing improvement in the pharmacological and therapeutic properties of drugs is driving the revolution in novel drug delivery systems. Nanomedicine is widely explored nowadays for treatment of life threatening diseases, yet comes with various challenges and questions. The present study encapsulates the acute toxicological aspects of the Andrographis paniculata coupled with silver nanoparticles (AP-Ag NP). For acute toxicity studies according to OCED (Organization for Economic Cooperation and Development) guidelines Swiss Albino male mice (6-7 weeks) were used and were given single intraperitoneal dose of 2000 and 5000 mg/kg body weight of the AP-Ag nanoparticle and were observed for mortality and other side effects for 14 days. The individual components of the formulation, viz. silver oxide in surface modified nano form and at low dose, and Andrographis paniculata are both biocompatible materials. No changes were found for general appearance, behavior and body weight, thus concluding that the nanocomposite formulation does not have a single dose toxicity.
穿心莲绿色途径合成银纳米粒子的毒理学评价
文章历史:收到2018年10月12日接受2018年11月28日在线2019年3月16日纳米医学是纳米技术和医学的结合。它在“纳米”尺度的单分子或分子组合水平上为医学诊断、监测和治疗提供了新的方向。此外,药物药理和治疗特性的持续改进正在推动新型药物输送系统的革命。纳米医学在治疗危及生命的疾病方面得到了广泛的探索,但也面临着各种挑战和问题。本研究概括了穿心莲与银纳米粒子(AP-Ag NP)偶联的急性毒理学方面。根据OCED(经济合作与发展组织)指导方针进行急性毒性研究,使用瑞士白化雄性小鼠(6-7周),并给予单次腹腔剂量2000和5000 mg/kg体重的AP-Ag纳米颗粒,观察14天的死亡率和其他副作用。该配方的单个组分,即表面改性纳米形式和低剂量的氧化银和穿心莲都是生物相容性材料。总体外观、行为和体重没有变化,因此得出结论,纳米复合制剂不具有单剂量毒性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信